Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure

Cardiovascular Research

Volumn 54, Issue 2, 2002, Pages 456-461

  Shi, Yanfen ^a   Li, Danshi ^a   Tardif, Jean Claude ^a   Nattel, Stanley ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

ACE inhibitors; Arrhythmia (mechanisms); Atrial function; Fibrosis; Heart failure; Remodeling; Supraventr. arrhythmia

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFECT; ECHOCARDIOGRAPHY; ELECTROPHYSIOLOGY; FIBROSIS; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART RIGHT ATRIUM; HEART RIGHT VENTRICLE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT OUTCOME;

ACTION POTENTIALS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; DOGS; ECHOCARDIOGRAPHY; ENALAPRIL; HEART ATRIA; HEART FAILURE, CONGESTIVE; MODELS, ANIMAL;

EID: 0036216187     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00243-2     Document Type: Article

References (29)

1. Atrial arrhythmias
2. Atrial fibrillation in heart failure
3. Atrial fibrillation and congestive heart failure: The intersection of two common diseases
4. Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: A retrospective analysis of the SOLVD trials
5. Improving survival for patients with atrial fibrillation and advanced heart failure
6. Promotion of fibrillation by heart failure in dogs: Atrial remodeling of a different sort
7. Predictors of primary atrial fibrillation and concomitant clinical and hemodynamic changes in patients with chronic heart failure: A prospective study in 344 patients with baseline sinus rhythm
8. Biatrial appendage hypertrophy but not ventricular hypertrophy: A unique feature of canine pacing-induced heart failure
9. The pathophysiology of advanced heart failure
10. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction
11. Effects of angiotensin converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure
12. Experimental congestive heart failure produced by rapid ventricular pacing in the dog: Cardiac effects
13. Evaluation of changes in left ventricular end-diastolic pressure by left atrial two-dimensional echocardiography
14. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling
15. Cardiac anatomy and pathologic correlates of atrial fibrillation
16. Susceptibility to atrial fibrillation: A study in an ovine model of pacing-induced early heart failure
17. Mechanisms for atrial arrhythmias associated with cardiomyopathy: A study of feline hearts with primary myocardial disease
18. Effects of left atrial enlargement on atrial transmembrane potentials and structure in dogs with mitral valve fibrosis
19. DNA synthesis in the non-infarcted cardiac interstitium after left coronary artery ligation in the rat: Effects of captopril
20. Angiotensin II receptor blockade after myocardial infarction in rats: Effects on hemodynamics, myocardial DNA synthesis, and interstitial collagen content
21. Effects of β-receptor blockade and angiotensin II type I receptor antagonism in isoproterenol-induced heart failure in the rat
22. Collagen metabolism in cultured adult rat cardiac fibroblasts: Response to angiotensin II and aldosterone
23. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation
24. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans
25. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
26. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease
27. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat